SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-073217
Filing Date
2021-05-27
Accepted
2021-05-27 16:11:00
Documents
2
Period of Report
2021-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117528d1_8k.htm 8-K 18572
2 EXHIBIT 10.1 tm2117528d1_ex10-1.htm EX-10.1 71252
  Complete submission text file 0001104659-21-073217.txt   91149
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 21972777
SIC: 2834 Pharmaceutical Preparations